Duncan Wheatley

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Adrian Murray Brunt, Joanne Haviland, Duncan Wheatley et al. · The Lancet · 2020 · 1.1K citations · Full text

Medicine, Oncology, Surgery +17

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

Charlotte E. Coles, Clare Griffin, Anna M. Kirby et al. · The Lancet · 2017 · 612 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer

Isaac García-Murillas, Neha Chopra, Iñaki Comino‐Méndez et al. · JAMA Oncology · 2019 · 428 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

Peter Schmid, Jacinta Abraham, Stephen Chan et al. · Journal of Clinical Oncology · 2019 · 389 citations · Full text

Medicine, Oncology, Pharmacology +16